Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2025-12-25 @ 3:24 AM
NCT ID:
NCT00110305
Eligibility Criteria:
Inclusion Criteria:
* Documented human immunodeficiency virus type 1 (HIV-1) infection
* Never been treated with an antiretroviral (ARV) treatment or therapeutic HIV vaccine, or received less than or equal to 2 weeks treatment prior to screening with an nucleoside reverse transcriptase inhibitors
* HIV-1 plasma viral load above 5000 HIV-1 RNA copies per milliliter, at screening
* Cortisol of at least 550 nano moles per liter (19.9 microgram per deciliter) at screening
* Sensitivity to investigator selected nucleosides, at screening
Exclusion Criteria:
* Currently having active Acquired Immunodeficiency Syndrome (AIDS) defining illness
* Known or suspected acute (primary) HIV-1 infection
* Any current or history of adrenal disorder, and an acute hepatitis A, B, or C infection
* Documented genotypic evidence of Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) resistance at screening
* Pregnant or breastfeeding females
* Not agree to protocol-defined effective use of contraception
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00110305
Study Brief:
Protocol Section:
NCT00110305